Added to YB: 2026-02-20
Pitch date: 2026-02-18
LFCR [neutral]
Lifecore Biomedical, Inc.
-2.04%
current return
Author Info
No bio for this author
Company Info
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally.
Market Cap
$268.3M
Pitch Price
$7.35
Price Target
N/A
Dividend
N/A
EV/EBITDA
-119.93
P/E
-5.62
EV/Sales
3.39
Sector
Life Sciences Tools and Services
Category
special_situation
Watchlist Radar - Lifecore Biomedical, Inc.
LFCR (watchlist): CDMO specializing in injectables, fastest-growing pharma segment. Operating at ~15% EBITDA margins with only 20% capacity utilization post-expansion. High switching costs create sticky customers. Last remaining small public CDMO; mgmt targeting sale in 2yrs. Precedent M&A multiples imply significant upside vs current $410M EV.
Read full article (1 min)